New CAR T-Cell Therapy Approved for Leukemia
MedPage Today) — The FDA approved obecabtagene autoleucel (obe-cel; Aucatzyl) for treating relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adults, the agency announced on Friday. Of note, unlike other CAR T-cell…
MedPage Today) — The FDA approved obecabtagene autoleucel (obe-cel; Aucatzyl) for treating relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adults, the agency announced on Friday.
Of note, unlike other CAR T-cell…
Read More
About Author
